<DOC>
	<DOCNO>NCT00315640</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy anecortave acetate depot administer treatment elevate IOP follow treatment steroid .</brief_summary>
	<brief_title>Anecortave Acetate Treatment Steroid Induced Intraocular Pressure ( IOP ) Elevation</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Either gender 18 year age old IOP elevation cause steroid usage Other protocoldefined inclusion criterion may apply Under 18 year age Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Elevated IOP due intravitreal triamcinolone therapy</keyword>
</DOC>